Antibiotic prophylaxis for transperineal prostate biopsy

Yu-Tian Xiao; Yu Yang; Xuejiao Wu; Shi Yan; Yasheng Zhu; Mengyin Chen; Wei He; Onuralp Ergun; Philipp Dahm; Juan Va Franco

doi:10.1002/14651858.CD015990

Antibiotic prophylaxis for transperineal prostate biopsy

Cochrane Database Syst Rev. 2025 Oct 29;10(10):CD015990. doi: 10.1002/14651858.CD015990.

Authors

Yu-Tian Xiao¹, Yu Yang², Xuejiao Wu³, Shi Yan⁴, Yasheng Zhu⁵, Mengyin Chen⁶, Wei He⁵, Onuralp Ergun^{7

8}, Philipp Dahm⁸, Juan Va Franco⁹

Affiliations

¹ Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna, Austria.
² Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
³ Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
⁴ Department of Urology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
⁵ Department of Urology, Shanghai Changhai Hospital, Shanghai, China.
⁶ Department of Lung Transplantation, China-Japan Friendship Hospital, Beijing, China.
⁷ Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA.
⁸ Urology Section, Minneapolis VA Health Care System, Minneapolis, Minnesota, USA.
⁹ Institute of General Practice, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of antibiotic prophylaxis versus no antibiotic prophylaxis in people undergoing transperineal prostate biopsy.

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antibiotic Prophylaxis* / adverse effects
Biopsy / adverse effects
Biopsy / methods
Humans
Male
Perineum
Prostate* / pathology
Randomized Controlled Trials as Topic

Substances

Anti-Bacterial Agents